Hansa Biopharma (Sweden) Statistic Functions Beta
| HNSA Stock | SEK 30.68 0.80 2.68% |
| Symbol |
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Hansa Biopharma AB correlated with the market. If Beta is less than 0 Hansa Biopharma generally moves in the opposite direction as compared to the market. If Hansa Biopharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hansa Biopharma AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hansa Biopharma is generally in the same direction as the market. If Beta > 1 Hansa Biopharma moves generally in the same direction as, but more than the movement of the benchmark.
Hansa Biopharma Technical Analysis Modules
Most technical analysis of Hansa Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Hansa from various momentum indicators to cycle indicators. When you analyze Hansa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Hansa Biopharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hansa Biopharma AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hansa Biopharma AB based on widely used predictive technical indicators. In general, we focus on analyzing Hansa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hansa Biopharma's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Hansa Biopharma's intrinsic value. In addition to deriving basic predictive indicators for Hansa Biopharma, we also check how macroeconomic factors affect Hansa Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Hansa Stock Analysis
When running Hansa Biopharma's price analysis, check to measure Hansa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hansa Biopharma is operating at the current time. Most of Hansa Biopharma's value examination focuses on studying past and present price action to predict the probability of Hansa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hansa Biopharma's price. Additionally, you may evaluate how the addition of Hansa Biopharma to your portfolios can decrease your overall portfolio volatility.